COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR

• 1. 具有抗癌活性的6‑氧代‑1,6‑二氢‑哒嗪衍生物与EGFR抑制剂的组合 [P] . 中国专利： CN106999493A . 2017-08-01
• 2. 具有抗癌活性的6-氧代-1,6-二氢-哒嗪衍生物与喹唑啉衍生物的组合 [P] . 中国专利： CN106999492B . 2020.12.11
• 3. Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor [P] . 美国专利： US10532052B2 . 2020-01-14

  机译： 具有抗癌活性的6-氧代-1,6-二氢哒嗪衍生物与EGFR抑制剂的组合

• 4. Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor [P] . 美国专利： US2019388423A1 . 2019-12-26

  机译： 具有抗癌活性的6-氧代-1,6-二氢哒嗪衍生物与EGFR抑制剂的组合

• 5. COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR [P] . ZA201704654B . 2019-08-28

  机译： 具有抗癌活性的6-OXO-1,6-二氢哒嗪衍生物与EGFR抑制剂的组合

• 1. Computer-Aid Design of Novel Sulfonamide Derivatives as EGFR Kinase Inhibitors for Cancer Treatment [J] . Souad Akili, Djamila Ben Hadda, Yasser Bitar, 有机化学国际期刊（英文） . 2021,第004期
• 2. 397 POSTER Potentiation of the antitumor activity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines [J] . T.Cascone, F.Morgillo, G.Laus, European Journal of Cancer Supplements . 2006,第12期
• 3. 399 POSTER Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines [J] . E.Martinelli, T.Troiani, G.Laus, European Journal of Cancer Supplements . 2006,第12期
• 4. Combination of radial distribution functions as structural descriptors with ligand-receptor interaction information in the QSAR study of some 4-anilinoquinazoline derivatives as potent EGFR inhibitors [J] . Structural Chemistry . 2020,第4期
• 5. DESIGN AND SYNTHESIS OF SOME NOVEL ERLOTINIB DERIVATIVES AS POTENTIAL EGFR KINASE INHIBITORS [C] . V.Ajeesh, S.Shubham, M.Ruchi Conference on Drug Design and Discovery Technologies . 2020
• 6. GGTI-298 in combination with EGFR inhibitors: Evaluating a novel therapy in head and neck squamous cell carcinomas. [D] . Zahr, Stephanie. 2013
• 7. Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells [O] . Yan Zhang, Qin Wang, Luolan Li, 2021
• 8. Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells [O] . Yan Zhang, Qin Wang, Luolan Li, 2021

• 1. In Vitro Anti-viral Activities and Structure-activity Relationship Studies of Flavones and Dihydroflavone Derivatives as Influenza Virus Potential Neuraminidase Inhibitors [J] . SUN Jia-Ying ,HE Yun-Qing ,DU Hui-Rong . 结构化学 . 2015,第011期
• 2. Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines [J] . Gerhard Hamilton ,Ulrike Olszewski Lukas Klameth ,Ernst Ulsperger . 癌症治疗（英文） . 2013,第8期
• 3. Anti-esophagus cancer activity and mechanism of DN3,a novel natural diterpenoid derivative,as a dual inhibitor of glycolysis and oxidative phosphorylation [J] . Yong-cheng MA ,Ying-li ZHU ,Xia-xia FAN . 中国药理学与毒理学杂志 . 2018,第004期
• 4. Exploring QSARs for Inhibitory Activity of Cyclic Urea and Nonpeptide-Cyclic Cyanoguanidine Derivatives HIV-1 Protease Inhibitors by Artificial Neural Network [J] . Omar Deeb ,Mohammad Jawabreh . 化学工程与科学期刊（英文） . 2012,第1期
• 5. 化学杂交剂１－芳基－１，４－二氢－４－氧（硫）哒嗪衍生物的二维结构－选择性雄性不育活性关系研究 [C] . 周家驹 ,陈万义 . 全国第三届化工过程数学模拟与分析学术会议 . 1994
• 6. 6-（4-取代乙酰氨基苯基）-4，5-二氢-3（2H）-哒嗪酮衍生物的合成及其抑制血小板聚集活性 [A] . 孙亮 . 2008